Rintatolimod: with IFN for melanoma, colorectal cancer, prostate cancerWith pembrolizumab and cisplatin for ovarian cancerWith IFN and neoadjuvant chemotherapy for breast cancer. Here, IFNA1 is linked to breast cancer.